kabutan

KISSEI PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 13%

Mon Feb 3, 2025 3:30 pm JST Earnings

4547 KISSEI PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KISSEI PHARMACEUTICAL CO.,LTD. <4547> [TSE Prime] announced its financial results after the market closed on February 3rd (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 13.1% from the same period last year to 5.29 billion yen. The progress rate toward the full-year plan of 6 billion yen was 88.3%, below the same period of the previous year of 99.3%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 17 times that of the same period last year, reaching 0.7 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 16.2% from the same period last year, reaching 3.06 billion yen. The operating profit margin rose from 10.3% in the same period last year to 10.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 51,635 492 2,113 6,667 144.6 353.3 Jan 31, 2023 J-GAAP
Apr - Dec, 2023 57,859 4,164 6,100 8,337 182.9 99.3 Jan 30, 2024 J-GAAP
Apr - Dec, 2024 65,669 4,238 5,298 8,840 201.4 88.3 Feb 3, 2025 J-GAAP
YoY +13.5% +1.8% -13.1% +6.0% +10.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 38,601 2,002 2,677 5,482 121.1 41 May 7, 2024 J-GAAP
Oct - Mar, 2024 Guidance 44,034 3,219 3,763 6,451 150.7 45 Nov 5, 2024 J-GAAP
YoY +14.1% +60.8% +40.6% +17.7% +24.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 67,493 -1,129 598 10,528 228.3 80 May 8, 2023 J-GAAP
Mar, 2024 75,579 4,017 6,142 11,160 246.6 82 May 7, 2024 J-GAAP
Mar, 2025 Guidance 86,500 5,000 6,000 11,700 273.3 90 Nov 5, 2024 J-GAAP
YoY +14.4% +24.5% -2.3% +4.8% +10.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 20,881 2,149 2,635 2,659 58.3 10.3 Jan 30, 2024 J-GAAP
Jan - Mar, 2024 17,720 -147 42 2,823 62.4 -0.8 May 7, 2024 J-GAAP
Apr - Jun, 2024 21,164 2,158 2,876 4,106 92.9 10.2 Jul 30, 2024 J-GAAP
Jul - Sep, 2024 21,302 -377 -639 1,143 25.9 -1.8 Nov 5, 2024 J-GAAP
Oct - Dec, 2024 23,203 2,457 3,061 3,591 81.8 10.6 Feb 3, 2025 J-GAAP
YoY +11.1% +14.3% +16.2% +35.1% +40.3%

Related Articles